Found: 102
Select item for more details and to access through your institution.
GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1135, doi. 10.1007/s10637-019-00741-3
- By:
- Publication type:
- Article
Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1206, doi. 10.1007/s10637-015-0286-7
- By:
- Publication type:
- Article
Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 500, doi. 10.1007/s10637-013-0060-7
- By:
- Publication type:
- Article
Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1142, doi. 10.1007/s10637-013-9932-0
- By:
- Publication type:
- Article
Antiangiogenic treatments and mechanisms of action in renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1791, doi. 10.1007/s10637-011-9677-6
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of etaracizumab (Abegrinâ¢), a humanized monoclonal antibody against α<sub>v</sub>β<sub>3</sub> integrin receptor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 1, p. 35, doi. 10.1007/s10637-007-9077-0
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2Â weeks in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 5, p. 453, doi. 10.1007/s10637-007-9071-6
- By:
- Publication type:
- Article
Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx<sup>®</sup>) in combination with topotecan in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 5, p. 413
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 311, doi. 10.1007/s10637-005-5055-6
- By:
- Publication type:
- Article
Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 3, p. 225, doi. 10.1007/s10637-005-6730-3
- By:
- Publication type:
- Article
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 268, doi. 10.1159/000522418
- By:
- Publication type:
- Article
Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 13, p. 1702, doi. 10.3390/cells12131702
- By:
- Publication type:
- Article
Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib.
- Published in:
- Therapeutic Advances in Gastroenterology, 2013, v. 6, n. 5, p. 396, doi. 10.1177/1756283X13493878
- By:
- Publication type:
- Article
From Van Gogh to Lady Gaga: Artist eccentricity increases perceived artistic skill and art appreciation.
- Published in:
- European Journal of Social Psychology, 2014, v. 44, n. 2, p. 93, doi. 10.1002/ejsp.1999
- By:
- Publication type:
- Article
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances.
- Published in:
- Molecular Diagnosis & Therapy, 2024, v. 28, n. 2, p. 201, doi. 10.1007/s40291-023-00692-9
- By:
- Publication type:
- Article
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11065-0
- By:
- Publication type:
- Article
The Role of Integrins in Colorectal Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, p. 21
- By:
- Publication type:
- Article
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1468, doi. 10.1111/liv.14113
- By:
- Publication type:
- Article
Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 2, p. 313, doi. 10.1007/s11060-014-1710-0
- By:
- Publication type:
- Article
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156382
- By:
- Publication type:
- Article
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Stromal expression of SPARC in pancreatic adenocarcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2013, v. 32, n. 3/4, p. 585, doi. 10.1007/s10555-013-9439-3
- By:
- Publication type:
- Article
Targeting the Ras-ERK pathway in pancreatic adenocarcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2013, v. 32, n. 1/2, p. 147, doi. 10.1007/s10555-012-9396-2
- By:
- Publication type:
- Article
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors.
- Published in:
- Cancer & Metastasis Reviews, 2011, v. 30, p. 19, doi. 10.1007/s10555-011-9291-2
- By:
- Publication type:
- Article
Future perspectives on neuroendocrine tumors.
- Published in:
- Cancer & Metastasis Reviews, 2011, v. 30, p. 35, doi. 10.1007/s10555-011-9294-z
- By:
- Publication type:
- Article
Clinical Activity of Lenalidomide in Visceral Human Immunodeficiency Virus-Related Kaposi Sarcoma.
- Published in:
- JAMA Dermatology, 2013, v. 149, n. 11, p. 1319, doi. 10.1001/jamadermatol.2013.5751
- By:
- Publication type:
- Article
Sunitinib.
- Published in:
- BioDrugs, 2011, v. 25, n. 5, p. 307, doi. 10.2165/11207360-000000000-00000
- By:
- Publication type:
- Article
Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?
- Published in:
- 2005
- By:
- Publication type:
- letter
Methods for Inclusive Underwriting of Breast Cancer Risk with Machine Learning and Innovative Algorithms.
- Published in:
- Journal of Insurance Medicine, 2023, v. 50, n. 1, p. 36, doi. 10.17849/insm-50-1-36-48.1
- By:
- Publication type:
- Article
Management of unexpected laboratory exposure to Burkholderia pseudomallei.
- Published in:
- Annales de Biologie Clinique, 2023, v. 81, n. 6, p. 640, doi. 10.1684/abc.2023.1854
- By:
- Publication type:
- Article
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 394, doi. 10.1634/theoncologist.2013-0114
- By:
- Publication type:
- Article
Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities.
- Published in:
- Oncologist, 2011, v. 16, n. 5, p. 543, doi. 10.1634/theoncologist.2010-0263
- By:
- Publication type:
- Article
Up from Alchemy.
- Published in:
- IEEE Software, 2004, v. 21, n. 1, p. 88, doi. 10.1109/MS.2004.1259228
- By:
- Publication type:
- Article
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 9/10, p. 1168, doi. 10.1080/0284186X.2016.1191670
- By:
- Publication type:
- Article
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A TALE OF TWO CITIES: AN EXPLORATORY STUDY OF CONSOLIDATION AND ANNEXATION POLICIES IN THE CITIES OF MEMPHIS AND NASHVILLE.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Interview: LifeBiotic Founder, Yair Maimon, DOM, PhD, AC.
- Published in:
- JASA: Journal of the American Society of Acupuncturists, 2020, v. 7, n. 4, p. 41
- By:
- Publication type:
- Article
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure.
- Published in:
- BJU International, 2013, v. 111, n. 1, p. 44, doi. 10.1111/j.1464-410X.2012.11404.x
- By:
- Publication type:
- Article
Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterasesensitive cross-linker in patients with advanced malignancies: a Phase I study.
- Published in:
- International Journal of Nanomedicine, 2016, v. 11, p. 6207, doi. 10.2147/IJN.S110274
- By:
- Publication type:
- Article
Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 1, p. 9, doi. 10.1177/1758834011428147
- By:
- Publication type:
- Article
To the editor.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 20, p. 4981, doi. 10.1002/cncr.27520
- By:
- Publication type:
- Article
Pandemic Influenza Planning: An Extraordinary Ethical Dilemma for Local Government Officials.
- Published in:
- Public Administration Review, 2009, v. 69, n. 5, p. 823, doi. 10.1111/j.1540-6210.2009.02032.x
- By:
- Publication type:
- Article
The Cathedral and the Bazaar.
- Published in:
- Knowledge, Technology & Policy, 1999, v. 12, n. 3, p. 23, doi. 10.1007/s12130-999-1026-0
- By:
- Publication type:
- Article
Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2013, v. 35, n. 12, p. 1819, doi. 10.1002/hed.23217
- By:
- Publication type:
- Article
La chirurgie d'exérèse exclusive du carcinome épidermoïde T1 du canal anal : un débat loin d'être tranché ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2021, v. 28, n. 9, p. 1060, doi. 10.1684/hpg.2021.2250
- By:
- Publication type:
- Article